Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Goldman Upgrades Booker, Panmure Cuts Meggitt

Wed, 18th May 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
JEFFERIES CUTS STANDARD CHARTERED TARGET TO 330 (400) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 265 (260) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS ITV PRICE TARGET TO 230 (240) PENCE - 'HOLD'
----------
Deutsche Bank Ups Taylor Wimpey Target To 261p From 247p, Keeps Buy
----------
EXANE BNP RAISES ASHTEAD GROUP TO 'OUTPERFORM' ('NEUTRAL') - TARGET 1,050 (900) PENCE
----------
CREDIT SUISSE RAISES TRAVIS PERKINS TARGET TO 2,250 (2,200)P - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES BHP BILLITON PRICE TARGET TO 1050 (900) PENCE - 'OUTPERFORM'
----------
FTSE 250
----------
PANMURE CUTS MEGGITT TO 'SELL' ('HOLD') - TARGET 325 (363) PENCE
----------
LIBERUM RAISES RIGHTMOVE PRICE TARGET TO 5,000 (4,295) PENCE - 'BUY'
----------
Numis Downgrades Marshalls To Add From Buy, Target At 400p
----------
GOLDMAN RAISES BOOKER GROUP TO 'BUY' ('NEUTRAL') - TARGET 198 (171) PENCE
----------
BERENBERG INITIATES JUST EAT WITH 'BUY' - TARGET 530 PENCE
----------
Deutsche Bank Cuts BTG Target To 740p From 755p, Keeps Buy
----------
EXANE BNP CUTS VICTREX PRICE TARGET TO 1,500 (1,650) PENCE - 'NEUTRAL'
----------
SOCGEN RAISES INTERMEDIATE CAPITAL PRICE TARGET TO 725 (660) PENCE - 'BUY'
----------
EXANE BNP CUTS ICAP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 475 (550) PENCE
----------
CREDIT SUISSE CUTS SHAWBROOK PRICE TARGET TO 380 (400) PENCE - 'OUTPERFORM'
----------
MAIN MARKET AND AIM
----------
PANMURE CUTS SCANCELL HOLDINGS PRICE TARGET TO 68 (79) PENCE - 'BUY'
----------
PANMURE CUTS JOHNSTON PRESS PRICE TARGET TO 200 (230) PENCE - 'BUY'
----------
Panmure Cuts Haynes Publishing Target To 150p From 200p, Keeps Buy
----------
PANMURE RAISES HILL & SMITH PRICE TARGET TO 1,100 (950) PENCE - 'BUY'
----------
TRADERS: MERRILL LYNCH REMOVES GENEL ENERGY FROM 'EMERGING EMEA 1' LIST
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
22 Jul 2020 11:24

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

Read more
24 Jun 2020 12:18

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Read more
12 Jun 2020 12:59

Scancell upbeat on publication of AvidiMab research

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.

Read more
28 Apr 2020 16:40

Director dealings: Scancell director lowers stake

(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.

Read more
28 Apr 2020 14:43

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Read more
24 Apr 2020 12:00

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Read more
24 Apr 2020 10:49

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

Read more
3 Feb 2020 14:20

Scancell's 'SCIB1' clears latest regulatory hurdle in US

(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.

Read more
3 Feb 2020 10:44

Scancell Gets US FDA Approval For SCIB1 Drug Application

Scancell Gets US FDA Approval For SCIB1 Drug Application

Read more
31 Jan 2020 11:12

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Read more
20 Jan 2020 12:04

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Read more
18 Dec 2019 16:29

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

Read more
16 Dec 2019 13:30

Scancell inks AvidiMab agreement with Chinese biotech company

(Sharecast News) - Scancell Holdings on Monday signed a collaboration and non-exclusive research agreement with an unnamed Chinese biotechnology firm.

Read more
16 Dec 2019 09:21

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Read more
12 Dec 2019 14:23

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.